146 related articles for article (PubMed ID: 6136239)
1. Neuroleptic malignant syndrome.
Weinberg S; Twersky RS
Anesth Analg; 1983 Sep; 62(9):848-50. PubMed ID: 6136239
[No Abstract] [Full Text] [Related]
2. [Malignant neuroleptic syndrome].
Devos P; Destee A; Warot P
LARC Med; 1984 May; 4(5):316-9. PubMed ID: 6147732
[No Abstract] [Full Text] [Related]
3. The neuroleptic malignant syndrome.
Kimsey LR; Gibbs JT; Glen RS; Markette JR; Kosted E
Tex Med; 1983 Oct; 79(10):54-5. PubMed ID: 6138871
[No Abstract] [Full Text] [Related]
4. [The enhanced neuroleptic therapy and malignant syndrome].
Jiang ZN
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Apr; 16(2):84-6. PubMed ID: 6137330
[No Abstract] [Full Text] [Related]
5. Malignant neuroleptic syndrome--its present status in Japan and clinical problems.
Itoh H; Ohtsuka N; Ogita K; Yagi G; Miura S; Koga Y
Folia Psychiatr Neurol Jpn; 1977; 31(4):559-76. PubMed ID: 608659
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome.
Feldman J
JAMA; 1984 Feb; 251(6):727-8. PubMed ID: 6141299
[No Abstract] [Full Text] [Related]
7. [Drug side effects on the nervous system].
Ludin HP
Ther Umsch; 1993 Jan; 50(1):23-7. PubMed ID: 8104359
[TBL] [Abstract][Full Text] [Related]
8. The neuroleptic malignant syndrome.
Caroff SN
J Clin Psychiatry; 1980 Mar; 41(3):79-83. PubMed ID: 6101595
[TBL] [Abstract][Full Text] [Related]
9. [Some clinical features of the malignant neuroleptic syndrome].
Volkov VP
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):75-8. PubMed ID: 22611685
[No Abstract] [Full Text] [Related]
10. Neuroleptic malignant syndrome.
Cummins P
Br J Psychiatry; 1984 May; 144():556. PubMed ID: 6145478
[No Abstract] [Full Text] [Related]
11. Questions about dantrolene for neuroleptic malignant syndrome.
Henderson VW
Am J Psychiatry; 1983 Jan; 140(1):137-9. PubMed ID: 6128926
[No Abstract] [Full Text] [Related]
12. [Malignant neuroleptic syndrome].
Courtine JC; Blot P
Nouv Presse Med; 1981 May; 10(21):1749. PubMed ID: 6112732
[No Abstract] [Full Text] [Related]
13. Neuroleptic malignant syndrome and malignant hyperthermia.
Caroff S; Rosenberg H; Gerber JC
J Clin Psychopharmacol; 1983 Apr; 3(2):120-1. PubMed ID: 6132930
[No Abstract] [Full Text] [Related]
14. [The malignant neuroleptic syndrome].
Hilpert F; Cohen A; Auzépy P
Rev Prat; 1984 Mar; 34(13):633-9. PubMed ID: 6143390
[No Abstract] [Full Text] [Related]
15. Therapy of syndrome malin.
Conner CS
Drug Intell Clin Pharm; 1983 Sep; 17(9):639-40. PubMed ID: 6137352
[TBL] [Abstract][Full Text] [Related]
16. Detection and management of the neuroleptic malignant syndrome.
Bond WS
Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome. Successful treatment with bromocriptine.
Mueller PS; Vester JW; Fermaglich J
JAMA; 1983 Jan; 249(3):386-8. PubMed ID: 6129331
[No Abstract] [Full Text] [Related]
18. [Amantadine in malignant neuroleptic syndrome].
Rojtman M; Apter E; Lahav S; Tiano S
Harefuah; 1981 Apr; 100(7):333. PubMed ID: 6115795
[No Abstract] [Full Text] [Related]
19. [Neuroleptics in children].
Daléry J; Beaufrère B; Maillet J; de Villard R
Pediatrie; 1980; 35(1):89-94. PubMed ID: 6102756
[No Abstract] [Full Text] [Related]
20. Neuroleptic malignant syndrome associated with loxapine.
Ewert AL; Kloek J; Wells B; Phelps S
J Clin Psychiatry; 1983 Jan; 44(1):37-8. PubMed ID: 6822486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
